Stevens M, Piepers S, Supré K, Dewulf J, De Vliegher S
M-team and Mastitis and Milk Quality Research Unit, Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
M-team and Mastitis and Milk Quality Research Unit, Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
J Dairy Sci. 2016 Mar;99(3):2118-2130. doi: 10.3168/jds.2015-10199. Epub 2016 Jan 6.
The main objective of this study was to quantify the (compound-specific) antimicrobial consumption (AMC) in adult cattle in a convenience sample of Flemish dairy herds. Antimicrobial consumption data were obtained between 2012 and 2013 by "garbage can audits" and expressed as antimicrobial treatment incidence (ATI), with the unit of the ATI being the number of defined daily doses animal (DDDA) used per 1,000 cow-days. Herds were stratified by DDDA into low-, medium-, and high-consuming herds to study the AMC per route of administration, and associations with parameters reflecting udder health, milk quality, and production performances were examined. The average ATI in adult dairy cattle for all compounds was 20.78 DDDA (per 1,000 cow-days). Large variation existed between herds (ranging from 8.68 to 41.62 DDDA). Fourth-generation cephalosporins were used most (4.99 DDDA), followed by penicillins (3.70 DDDA) and third-generation cephalosporins (2.95 DDDA). The average ATI of the critically important antimicrobials for human health (i.e., third- and fourth-generation cephalosporins and fluoroquinolones according to the World Organisation for Animal Health classification) was somewhat lower than the average ATI of the other antimicrobials (8.59 and 12.18 DDDA, respectively). The average ATI for intramammary treatment of (sub)clinical mastitis, for dry-cow therapy, and for systemically administered antimicrobials was 6.30, 6.89, and 7.44 DDDA, respectively. In low-consuming herds, most antimicrobials were being used for dry-cow therapy, whereas in high-consuming herds, most antimicrobials were being used as injectable or intramammary mastitis therapy. The incidence rate of treated mastitis was positively associated with ATI. Herds that applied blanket dry-cow therapy tended to have a higher ATI than herds in which cows were selectively dried off with long-acting antimicrobials. The ATI decreased with an increasing prevalence of primiparous cows.
本研究的主要目的是对佛兰德奶牛场便利样本中的成年奶牛(特定化合物)抗菌药物消费量(AMC)进行量化。2012年至2013年期间,通过“垃圾桶审计”获取抗菌药物消费数据,并以抗菌药物治疗发生率(ATI)表示,ATI的单位是每1000头奶牛日使用的限定日剂量动物数(DDDA)。根据DDDA将牛群分为低消费、中等消费和高消费牛群,以研究每种给药途径的AMC,并检查与反映乳房健康、牛奶质量和生产性能的参数之间的关联。成年奶牛所有化合物的平均ATI为20.78 DDDA(每1000头奶牛日)。牛群之间存在很大差异(范围为8.68至41.62 DDDA)。使用最多的是第四代头孢菌素(4.99 DDDA),其次是青霉素(3.70 DDDA)和第三代头孢菌素(2.95 DDDA)。对人类健康至关重要的抗菌药物(即根据世界动物卫生组织分类的第三代和第四代头孢菌素以及氟喹诺酮类)的平均ATI略低于其他抗菌药物的平均ATI(分别为8.59和12.18 DDDA)。用于(亚)临床乳腺炎乳房内治疗、干奶牛治疗和全身给药抗菌药物的平均ATI分别为6.30、6.89和7.44 DDDA。在低消费牛群中,大多数抗菌药物用于干奶牛治疗,而在高消费牛群中,大多数抗菌药物用作注射或乳房内乳腺炎治疗。治疗乳腺炎的发病率与ATI呈正相关。采用全面干奶牛治疗的牛群的ATI往往高于使用长效抗菌药物对奶牛进行选择性干奶的牛群中的ATI。随着初产奶牛患病率的增加,ATI降低。